Although the proposed rule has been quieter than many expected, recent FDA communications confirm that Front-of-Package (FOP) nutrition labelling remains very much on the agency’s agenda. Here’s what has happened since the proposal was released—and why manufacturers should start preparing now.
When the U.S. Food and Drug Administration (FDA) published its proposed Front-of-Package (FOP) nutrition labelling rule in January 2025, it represented one of the most significant food labelling initiatives in decades. The proposal would require many packaged foods sold in the United States to display simplified nutrition information directly on the front of the package, helping consumers quickly identify products that are high, medium, or low in saturated fat, sodium, and added sugars.
Following the U.S. presidential transition, however, many in the food industry questioned whether the proposal would survive under the new administration. Months passed without a final rule, leading some businesses to assume the initiative had quietly been abandoned.
That assumption is no longer accurate.
FDA has now confirmed that Front-of-Package nutrition labelling remains one of the Human Foods Program’s priority initiatives for 2026, signaling that the agency continues to advance the proposal despite the change in administration.
For food manufacturers, importers, private-label brands, and retailers, the message is increasingly clear: Front-of-Package labelling remains a matter of when, not if.
Diet-related chronic diseases, including obesity, cardiovascular disease, hypertension, and Type 2 diabetes—remain among the leading public health concerns in the United States.
Although the Nutrition Facts panel already provides detailed nutrition information, FDA concluded that many consumers either do not notice it or struggle to interpret it quickly while shopping. The proposed Front-of-Package system is intended to provide a simplified summary on the principal display panel, allowing consumers to compare products at a glance and make more informed purchasing decisions.
Unlike warning-label systems adopted elsewhere, FDA’s proposal uses interpretive categories—Low, Medium, and High—for three nutrients of public health concern:
These ratings would be displayed within a standardized Nutrition Info box located on the front of most packaged foods.
If finalized substantially as proposed, most foods currently required to carry a Nutrition Facts label would also require a Front-of-Package Nutrition Info box.
The proposal would establish:
FDA proposed implementation timelines of:
This is where many companies have lost track of the story.
After the proposed rule was published in January 2025, FDA received tens of thousands of public comments from industry, consumer organizations, academics, and other stakeholders. The comment period was later extended to allow additional feedback.
Following the administration change in 2025, many observers expected the proposal to stall indefinitely.
Instead, FDA’s recently released Human Foods Program 2026 Priority Deliverables confirms that Front-of-Package nutrition labelling remains an active regulatory priority.
According to FDA, the agency will:
Although FDA has not committed to a final publication date, the initiative is clearly progressing rather than being withdrawn.
While broad support exists for improving front-of-package nutrition communication, the exact label design remains an active area of debate.
FDA’s proposed Nutrition Info box is only one of several approaches studied internationally.
More than 40 countries now use some form of Front-of-Package nutrition labelling, including Canada, Chile, and Mexico. Many jurisdictions use “High In” warning labels, while others employ summary scoring systems such as Nutri-Score or Health Star Ratings.
Recent independent research has also questioned whether FDA’s proposed design is the most effective option.
A large randomized controlled trial published in The Lancet Public Health found that alternative “High In” warning-style labels helped consumers identify less healthy products more quickly and improved food selections compared with FDA’s proposed Nutrition Info box. Researchers suggested that designs highlighting only nutrients of concern may outperform the proposed Low/Medium/High format in helping consumers make healthier choices.
Whether FDA ultimately modifies its proposed design remains to be seen, but the research demonstrates that Front-of-Package labelling continues to evolve as new evidence emerges.
Experience from other jurisdictions suggests that mandatory Front-of-Package labelling often influences more than packaging.
Manufacturers frequently reformulate products to reduce sodium, added sugars, or saturated fat in order to avoid less favourable front-of-package designations.
FDA acknowledged in its economic analysis that some manufacturers may voluntarily reformulate products in response to the regulation, although reformulation itself is not required under the proposed rule.
Companies selling products internationally may already be familiar with similar initiatives.
Canada, for example, fully implemented mandatory Front-of-Package nutrition symbols on January 1, 2026, after a multi-year transition period. Many multinational food companies have already completed similar compliance exercises for the Canadian market.
Although the FDA rule has not yet been finalized, waiting until publication may significantly compress implementation timelines.
Preparing early allows companies to:
For companies marketing products in both Canada and the United States, there may also be opportunities to align regulatory strategies while recognizing that the two FOP systems are expected to differ in both design and nutrient thresholds.
Front-of-Package nutrition labelling represents another significant evolution in food regulatory compliance.
Whether your organization manufactures food products, imports products into North America, or manages private-label brands, understanding how the proposed FDA requirements may affect your portfolio today can reduce regulatory risk tomorrow.
dicentra’s food regulatory specialists monitor FDA policy developments, assess product compliance, review nutrition labelling, and help manufacturers prepare for upcoming regulatory changes before they become mandatory.
If your products may be affected by FDA’s proposed Front-of-Package labelling requirements, now is the time to begin evaluating your product portfolio and regulatory strategy. Contact dicentra to discuss how your business can prepare for the next phase of Front-of-Package nutrition labelling in the United States.